All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • DW5421APhase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia

  • DW5421BPhase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia

  • DWC202301Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects

  • DWC202313Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension

  • DWC202404Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Hypertension, Essential Hypertension

  • DWC202405Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension

  • DWC202517Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Healed Erosive Esophagitis

  • DWC202518Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · T2DM (Type 2 Diabetes Mellitus)

  • EA-230hourPhase 31 trial

    EBI Anti Sepsis BV · Coronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)

  • ELA026Phase 31 trial

    Electra Therapeutics Inc. · Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

  • ElenestinibBLU-263Phase 31 trial

    Blueprint Medicines Corporation · Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis

  • elsunersenPhase 31 trial

    Praxis Precision Medicines · Epileptic Encephalopathy, SCN2A Encephalopathy

  • ELVN-001Phase 31 trial

    Enliven Therapeutics · Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Chronic Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive CML

  • Amgen · Melanoma

  • Exa-celPhase 31 trial

    Vertex Pharmaceuticals · Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies

  • EXV-801deramciclanePhase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • EXV-802Phase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • F027Phase 31 trial

    Shandong New Time Pharmaceutical Co., LTD · Type 2 Diabetes (T2DM)

  • F520Phase 31 trial

    Shandong New Time Pharmaceutical Co., LTD · Cancer of Unknown Primary Site

  • Amgen · Melanoma

  • FDA018-ADCPhase 31 trial

    Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Triple Negative Breast Cancer

  • FDC laroprovstatPhase 31 trial

    AstraZeneca · Hypercholesterolemia

  • FDY-5301Phase 31 trial

    Faraday Pharmaceuticals, Inc. · Acute Myocardial Infarction, STEMI, Percutaneous Coronary Revascularization

  • FE 999049Rekovelle, Follitropin DeltaPhase 31 trial

    Ferring Pharmaceuticals · Infertility, Female

  • FHND9041Phase 31 trial

    Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Non Small Cell Lung Cancer

  • FiclatuzumabAV-299Phase 31 trial

    AVEO Pharmaceuticals, Inc. · Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma

  • FimasartanPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • Fixed of PertuzumabPhase 31 trial

    Roche (Genentech) · Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer

  • FlumatinibPhase 31 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia

  • Colgate Palmolive · Remineralization, Enamel Lesions, Enamel Subsurface Lesion

  • FRSW117Recombinant human coagulation factor Ⅷ-Fc fusion proteinPhase 31 trial

    Hangzhou Gensciences Biopharmaceutical Co., Ltd. · Severe Hemophilia A

  • FuzuloparibPhase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • GB06Phase 31 trial

    Kexing Biopharm Co., Ltd. · Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric

  • GB491Phase 31 trial

    Genor Biopharma Co., Ltd. · Breast Cancer

  • GC5103Undiluted .-Hepabig inj, Diluted .-Hepabig injPhase 31 trial

    GC Biopharma Corp · Hepatitis B

  • GC5107GCC 10% IGIVPhase 31 trial

    GC Biopharma Corp · Primary Immune Deficiency

  • GLSI-100Phase 31 trial

    Greenwich LifeSciences, Inc. · Breast Cancer

  • GME751Phase 31 trial

    Novartis · Metastatic NSCLC

  • GNR-055GNR-055 1.0-2.0Phase 31 trial

    AO GENERIUM · Mucopolysaccharidosis Type II, Metabolic Diseases

  • GNR-068Phase 31 trial

    AO GENERIUM · Plaque Psoriasis

  • GNR-086Phase 31 trial

    AO GENERIUM · Still's Disease Adult Onset

  • GQ1005Phase 31 trial

    GeneQuantum Healthcare (Suzhou) Co., Ltd. · HER2-positive Breast Cancer

  • GS101Phase 31 trial

    Jiangsu Genscend Biopharmaceutical Co., Ltd · Atopic Dermatitis (AD)

  • GTX-104Phase 31 trial

    Grace Therapeutics Inc. · Aneurysmal Subarachnoid Hemorrhage (aSAH)

  • HC-1119Phase 31 trial

    Hinova Pharmaceuticals Inc. · MCRPC

  • HCP1004Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Chronic Low-back Pain

  • HCP1803-4Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HDM1702Phase 31 trial

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Obesity Control

  • Hemay022Phase 31 trial

    Tianjin Hemay Pharmaceutical Co., Ltd · Breast Cancer

  • HGP1201Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Erectile Dysfunction

NewerPage 23 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.